======= DEGS1 ======= == Gene Information == * **Official Symbol**: DEGS1 * **Official Name**: delta 4-desaturase, sphingolipid 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8560|8560]] * **UniProt**: [[https://www.uniprot.org/uniprot/O15121|O15121]] * **Interactions**: [[https://thebiogrid.org/search.php?search=DEGS1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DEGS1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/615843|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Has sphingolipid-delta-4-desaturase activity. Converts D-erythro-sphinganine to D-erythro-sphingosine (E-sphing-4-enine). {ECO:0000269|PubMed:11937514}. |FA desaturase| |Lipid DES| |sphingolipid delta-4 desaturase activity| |unsaturated fatty acid biosynthetic process| |ceramide biosynthetic process| |electron transfer activity| |ceramide metabolic process| |sphingolipid biosynthetic process| |specific granule membrane| |unsaturated fatty acid metabolic process| |fatty acid biosynthetic process| |membrane lipid biosynthetic process| |sphingolipid metabolic process| |electron transport chain| |monocarboxylic acid biosynthetic process| |membrane lipid metabolic process| |carboxylic acid biosynthetic process| |organic acid biosynthetic process| |fatty acid metabolic process| |generation of precursor metabolites and energy| |neutrophil degranulation| |neutrophil activation involved in immune response| |neutrophil mediated immunity| |neutrophil activation| |granulocyte activation| |leukocyte degranulation| |myeloid leukocyte mediated immunity| |myeloid cell activation involved in immune response| |amide biosynthetic process| |monocarboxylic acid metabolic process| |lipid biosynthetic process| |myeloid leukocyte activation| |small molecule biosynthetic process| |leukocyte activation involved in immune response| |cell activation involved in immune response| |regulated exocytosis| |leukocyte mediated immunity| |cellular amide metabolic process| |exocytosis| |carboxylic acid metabolic process| |leukocyte activation| |endoplasmic reticulum membrane| |cellular lipid metabolic process| |oxidation-reduction process| |oxoacid metabolic process| |secretion by cell| |endoplasmic reticulum| |organic acid metabolic process| |export from cell| |cell activation| |immune effector process| |secretion| |lipid metabolic process| |mitochondrion| |integral component of plasma membrane| |organonitrogen compound biosynthetic process| |cellular nitrogen compound biosynthetic process| |small molecule metabolic process| |immune response| |vesicle-mediated transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|1.72| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|1.77| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|1.77| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|1.8| |[[:results:exp23|Nocodazole 0.02μM R00 exp23]]|1.87| |[[:results:exp452|Azithromycin 100μM R08 exp452]]|1.88| |[[:results:exp506|Momordin-Ic 10μM R08 exp506]]|1.88| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|1.96| |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|1.97| |[[:results:exp409|THZ531 0.11μM R07 exp409]]|2.01| |[[:results:exp22|MLN-4924 2μM R00 exp22]]|2.06| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|2.24| |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|2.48| |[[:results:exp240|Pyridostatin 4μM R05 exp240]]|2.52| |[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|2.7| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|2.71| |[[:results:exp444|THZ531 0.225μM R08 exp444]]|3.14| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|4| ^Gene^Correlation^ |[[:human genes:h:hars|HARS]]|0.442| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13382 * **Expression level (log2 read counts)**: 5.89 {{:chemogenomics:nalm6 dist.png?nolink |}}